Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis

COVID-19 patients with acute hypoxemic respiratory failure (AHRF) benefit from high flow nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation after HFNC failure are associated with poorer outcomes. The respiratory oxygenation (ROX) index, combining SpO(2)/FiO(2) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yau, Chun En, Lee, Dawn Yi Xin, Vasudevan, Adithi, Goh, Ken Junyang, Wong, Evelyn, Ho, Andrew Fu Wah, Lim, Daniel Yan Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441756/
https://www.ncbi.nlm.nih.gov/pubmed/37605238
http://dx.doi.org/10.1186/s13054-023-04567-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441756/
https://www.ncbi.nlm.nih.gov/pubmed/37605238
http://dx.doi.org/10.1186/s13054-023-04567-7

Ejemplares similares